Medirom holder Kufu exits ADS ownership stake

Kufu Company Holdings, Inc. filed Amendment No. 3 to its Schedule 13D concerning Medirom Healthcare Technologies Inc. American depositary shares.

Rhea-AI Filing Summary

Kufu Company Holdings, Inc. filed Amendment No. 3 to its Schedule 13D concerning Medirom Healthcare Technologies Inc. American depositary shares. The amendment reports that Kufu now beneficially owns 0 common shares and 0% of the class.

On July 14, 2026, bonds previously held by Kufu were redeemed in full. As a result, the reporting person has no voting or dispositive power over Medirom shares. This amendment is described as the final amendment and constitutes an exit filing for the reporting person.

Key Figures

Beneficially owned shares: 0.00 Percent of class: 0 % Bond redemption date: July 14, 2026 +1 more

4 metrics

Beneficially owned shares 0.00 Shares beneficially owned by Kufu Company Holdings, Inc. after July 14, 2026

Percent of class 0 % Percent of Medirom Healthcare Technologies Inc. ADSs beneficially owned by the reporting person

Bond redemption date July 14, 2026 Date on which bonds previously held by the reporting person were redeemed in full

Amendment number Amendment No. 3 Latest amendment to the beneficial ownership report, characterized as an exit filing

Key Terms

American depositary shares, beneficially owns, exit filing

3 terms

American depositary shares financial

"Title of Class of Securities: American depositary shares, each representing one common share"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

beneficially owns financial

"the Reporting Person no longer beneficially owns any Common Shares"

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

exit filing regulatory

"represents the final amendment to the and constitutes an exit filing"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What change does Kufu’s Amendment No. 3 report for Medirom (MRM)?

The amendment reports that Kufu Company Holdings now beneficially owns 0 Medirom common shares, representing 0% of the American depositary share class, and that this filing serves as Kufu’s final exit filing for its declared position.

How many Medirom (MRM) shares does Kufu now beneficially own?

Kufu Company Holdings reports beneficial ownership of 0.00 Medirom common shares, corresponding to 0% of the outstanding American depositary shares. The cover page also shows zero sole or shared voting and dispositive power over any Medirom securities.

What event led to Kufu’s exit from Medirom (MRM) ownership?

On July 14, 2026, bonds previously held by Kufu Company Holdings were redeemed in full. Following this redemption, Kufu no longer beneficially owns any Medirom common shares and thus filed this Schedule 13D Amendment No. 3 as an exit filing.

Is this Kufu’s final Schedule 13D amendment for Medirom (MRM)?

Yes. The amendment explicitly states that Amendment No. 3 is the final amendment to the prior beneficial ownership report and constitutes an exit filing for Kufu Company Holdings regarding Medirom Healthcare Technologies Inc. American depositary shares.

What voting and dispositive power does Kufu retain over Medirom (MRM) shares?

Kufu Company Holdings reports 0.00 sole voting power, 0.00 shared voting power, 0.00 sole dispositive power, and 0.00 shared dispositive power. These figures confirm that Kufu currently has no control over any Medirom securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/17/2026 - 04:05 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)

Medirom Healthcare Technologies Inc.

(Name of Issuer)

American depositary shares, each representing one common share, no par value

(Title of Class of Securities)

58510H103

(CUSIP Number)

Jun Kanma
c/o Kufu Company Holdings, Inc., Mita Ko, 1-4-28 Mita Minato-ku
Tokyo, M0, 108-0073
(813)6435-1687

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

07/14/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 58510H103

1

Name of reporting person

Kufu Company Holdings, Inc.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

JAPAN

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: American depositary shares, each representing one common share, no par value
(b)	Name of Issuer: Medirom Healthcare Technologies Inc.
(c)	Address of Issuer's Principal Executive Offices: 16F Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, JAPAN , 135-0091.
Item 1 Comment: SCHEDULE 13D - EXPLANATORY NOTE This Amendment No. 3 (this "Amendment No. 3") to statement on Schedule 13D, which was initially filed on January 6, 2023 and amended on May 30, 2025 and March 30, 2026 (as amended, the "Schedule 13D"), relates to the American depositary shares ("ADSs") of MEDIROM Healthcare Technologies Inc., a joint stock corporation with limited liability organized under the laws of Japan (the "Issuer"), whose principal executive offices are located at 16F Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo 135-0091. Each ADS represents one common share, no par value, of the Issuer (the "Common Shares"). This Amendment No. 3 amends and supplements the Schedule 13D to report that the Reporting Person is no longer the beneficial owner of any Common Shares. The filing of this Amendment No. 3 represents the final amendment to the Schedule 13D and constitutes an exit filing for the Reporting Person. Except as set forth herein, all Items of the Schedule 13D remain unchanged.
Item 4.	Purpose of Transaction
	Item 4 of the Schedule 13D is amended and supplemented to add the following: On July 14, 2026, the Bonds previously held by the Reporting Person were redeemed in full. As a result, the Reporting Person no longer beneficially owns any Common Shares.
Item 5.	Interest in Securities of the Issuer
(a)	The information contained in rows 7, 8, 9, 10, 11, 12 and 13 on the cover page of this Schedule 13D and in the footnotes thereto is incorporated herein by reference.
(b)	The information contained in rows 7, 8, 9, 10, 11, 12 and 13 on the cover page of this Schedule 13D and in the footnotes thereto is incorporated herein by reference.
(c)	The information in Items 3 and 4 of this Schedule 13D is incorporated herein by reference. The Reporting Person has not engaged in any transaction in ADSs in the 60 days prior to the filing of this Schedule 13D other than as described in Item 4.
(d)	None.
(e)	Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Kufu Company Holdings, Inc.

Signature:	/s/ Jun Kanma
Name/Title:	Jun Kanma/Director
Date:	07/16/2026